← Return to Cretastimogene Grenadenorepvec: Anyone in the PIVOT-006 Study?
DiscussionCretastimogene Grenadenorepvec: Anyone in the PIVOT-006 Study?
Bladder Cancer | Last Active: 5 days ago | Replies (16)Comment receiving replies
Replies to "Hello, I was diagnosed low grade NIMBC in December 2023, had TURBT, Mitomycin and a course..."
headed for treatment with Adstiladrin within 2 weeks, 2 TURBT's tested lesions and came back positive. The cost for this new drug is out of this world but trials have really been promising